Most Commons in Pulmonology
- Cough - Most common complaint seen in outpatient setting
- Dyspnea (difficulty breathing) - common complain at emergency department
- COPD - most common respiratory disease; 3rd leading cause of death in US
- More prevalent in males
- Most common cause of COPD - cigarette smoking
- Most common bacterial pathogens in COPD are: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
- Asthma - most common in children
- More common in male children
- Prevalence changes to adult women after puberty
- Most common in Caucasians
- Most are categorized as moderate persistent
- More common in obese individuals
- Most common Interstitial Lung Diseases
- (1) Usual Interstitial Pneumonia (idiopathic pulmonary fibrosis) - idiopathic interstitial pneumonia (IIP)
- (2) Sarcoidosis - idiopathic, granulomatous
- Idiopathic Interstitial Lung Disease - Most common type of Interstitial Lung Disease (ILD) or Diffuse Parenchymal Lung Disease
- Usual Interstitial Pneumonia (UIP) - most common Idiopathic Interstitial Pneumonia (IIP) and most common interstitial lung disease (ILD) overall
- Worse prognosis than other IIP: 3 year survival after diagnosis
- Smoking increases risk for development
- More common in men 50+ (middle aged or elderly)
- Anti-inflammatories worsen mortality
- When truly idiopathic, also known as idiopathic pulmonary fibrosis (PF): guidelines state that if you have a pathologic pattern of usual interstitial pneumonia and no known cause, you may use this term
- Note: recent treatment approved
- Sarcoidosis - most commonly presents in young African American women ages 10-40
- Reactivation mTB - most common in males 30-50 y/o
- Apical (hilar) infection most common
- Most common route of acquiring pneumonia is by aspiration of oropharyngeal secretions
- Community Acquired Pneumonia - most common causative agent is Streptococcus pneumoniae
- Twice as frequently during the winter in ages <5 and >65
- Nosocomial Pneumonia - most common infection in the intensive care unit
- Coccidiodomycosis - most commonly acquired in the summer/late fall during outdoor activities
- Allergic bronchopulmonary aspergillosis, pulmonary aspergilloma, angio-invasive aspergillosis - most common forms of Aspergillosis
- Aspergillosis - leading cause of death in acute leukemia, hematopoietic stem cell transplantation
- Most common species is aspergillus fumigatus
- Transudate - most common cause of a transudative effusion is congestive heart failure
- Pneumonia - most infectious disease in US
- Most common cause of death in pediatric population
- Most common cause of pneumonia in children: viral (RSV)
- Most common bacterial cause in children: S. pneumoniae
- Most common pathogen causing CAP: streptococcal pneumoniae
- Mycoplasma Pneumoniae - most common in 50 y/o
- Streptococcal Pneumoniae - most common in elderly and patients with comorbidities
- Haemophilus influenzae - most common in patients with comorbidities (COPD)
- Lung cancer - most prominent in African American men
- Most common cause of cancer death for men and women in US
- Most common cause of lung cancer among non-smokers: radon
- Non-Small Cell Carcinoma (NSCLC) - most common type of bronchogenic carcinoma
- Most common lung cancer subtype: adenocarcinoma (45-50%)
- Most commonly found in female non-smokers
- Leading cause of lung cancer: smoking
- Pulmonary Arterial Hypertension - most common in women 40-50 y/o
- Respiratory tract infections are the leading cause of mortality worldwide causing 3.9 million deaths in 2004 (WHO)
- Rhinovirus and Coronavirus - 2 most common viruses associated with common cold
- The “common cold” - the most frequent acute respiratory illness in the US
- Respiratory Syncytial Virus (RSV) - most common viral pathogen causing acute lower respiratory tract infection in young children (bronchiolitis)
- Most common cause of infant hospitalization in US
- Most children infected by age 3
- HCAP/HAP/VAP - most common MDR pathogen is Pseudomonas Aeruginosa
- Acute bronchitis - most commonly viral
- If longer than 3 weeks, considered chronic
- Pertussis - most common in children under the age of 1 (previously 1-5 y/o)
Other Helpful Hints
- Light’s Criteria - diagnostically differentiates between a transudative and exudative pleural effusion; not enough to formulate a diagnosis by itself
- Pleural fluid protein/serum protein ratio greater than 0.5
- Pleural fluid LDH/serum LDH ratio greater than 0.6
- Pleural fluid greater than ⅔ upper limit of normal serum LDH
- Exudate if any 1 of the above criteria is met, otherwise usually transudate
Disease
|
FVC
|
FEV1
|
FEV1/FVC
|
FEF25-75
|
FET
|
Obstructive
|
Normal
<80%
|
Decreased
<80%
|
Decreased
< 0.7
|
Decreased
<60%
|
Increased
|
Restrictive
|
Decreased
<80%
|
Normal or
Decreased
<80%
|
Normal or Increased
0.7
|
Normal
>60%
|
Normal
|
Mixed
|
Decreased
<80%
|
Decreased
<80%
|
Decreased
< 0.7
|
Decreased or Normal
<60%
|
Increased or Normal
|
- Tiffeneau index (FEV1/FVC x 100): % of FVC expired in one second
- FET = Forced Expiratory Time
- Pay Attention Here: The important thing to know about how to differentiate an obstructive vs. restrictive lung disease is based on their TLC, not the vital capacity, which will be decreased in obstructive lung diseases (this can be misleading).
Disease
|
TLC
|
FRC
|
TV
|
RV
|
VC
|
Obstructive
|
Increased
|
Increased
|
N
|
Increased
|
Decreased
|
Restrictive
|
Decreased
|
Decreased
|
N
|
Decreased
|
Decreased
|
- Obstructive vs. Restrictive Lung Diseases
- Obstructive Lung Diseases - chronic obstructive pulmonary disease, asthma, cystic fibrosis, bronchiectasis, and bronchiolar diseases (constrictive bronchiolitis, bronchiolitis obliterans syndrome)
- Restrictive Lung Diseases - interstitial lung diseases (ILD): sarcoidosis, chronic beryllium disease, hypersensitivity pneumonitis, pneumoconiosis, asbestos
Plethysmography Pattern
|
Feature
|
DLCO
|
Likely Dx
|
Obstructive
|
Hyperinflation (TLC >120%)
|
Decreased
|
Emphysema
|
Obstructive
|
Hyperinflation
|
Normal or Increased
|
Asthma
|
Obstructive
|
Normal lung volume
|
Normal
|
Chronic Bronchitis
|
Restrictive
|
Low RV
|
Decreased
|
Scar (Sarcoid or fibrosis)
|
Restrictive
|
Normal RV
|
Normal
|
Neuromuscular disease
|
GOLD I
|
Mild
|
No symptoms
Cough, sputum
Limited exercise capacity
Infrequent exacerbations
|
FEV1 > 80% predicted
|
GOLD II
|
Moderate
|
Significant limitation in exertional capacity
Limited ADLs
|
50% < FEV1 < 80%
|
GOLD III
|
Severe
|
SOB, even at rest
|
30% < FEV1 < 50%
|
GOLD IV
|
Very Severe
|
Frequent, severe exacerbations
|
FEV1 < 30% predicted
|
- Alpha-1 Antitrypsin Deficiency - autosomal co-dominant inheritance
- Most common PI*ZZ allele
- Suspect if
- COPD onset before age 45
- Unexplained liver disease, cirrhosis
- Absence of COPD risk factors
- Necrotizing panniculitis
- Unexplained bronchiectasis
- FH of any of above
- Caseating granulomas - hallmark lesion of tuberculosis
- Latent TB Infection - patients with latent tuberculosis are not infectious
- The main risk is reactivation mTB, also known as secondary TB
- PPD Skin Testing - “Never shake hands with TB on your Left”
- i.e. PPD tests are always performed on the patient’s right arm
- Quantiferon-TB Testing
- Cannot distinguish between active disease and latent infection
- CT Chest Findings: Aspergillosis
- Early: halo sign (i.e. an area of ground-glass infiltrate surrounding nodular densities)
- Late: crescent sign (i.e. air surrounding nodules, indicative of developing cavitation)
- Pulmonary Embolism Chest X-ray Findings
- Westermark Sign (oligemia): an abrupt cutoff of pulmonary vessels or dilation of pulmonary arteries proximal to embolus
- Hampton’s Hump: wedge shaped consolidation in the periphery against the pleural surface or a pleural based area of increased opacity
- Lung Cancer High Risk Factors - US Preventative Services Task Force
- 55-80 y/o
- 30 pack-year history of smoking
- Not quit within last 15 years
- Surgical candidate
- MRSA Risk Factors for Pneumonia
- Pleural effusion
- Recent Illness (including influenza infection)
- IVDA
- Multifocal infiltration (cavitations) on CXR
- ESRD
- Recent prior antibiotics (last 3 months)
Resources:
Pleural Diseases
Approach to the Patient with Pulmonary Disease, Dr. Orcutt
Pulmonary Function Tests, Dr. Dekat
Asthma, Dr. Dekat
Cecil’s Essentials of Medicine, 8th Edition, Thomas E. Andreoli
No comments:
Post a Comment
Leave a comment with feedback, questions, or inquiries for Paul. He will try to respond within 1-2 weeks.